FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Sudarshan Pharma IPO.
July 2, 2024 3:30:00 AM
Sudarshan Pharma Industries Ltd share price was down by -0.13% from the previous closing price of ?75.73. Who are peers of Sudarshan Pharma Industries Ltd? The peers of Sudarshan Pharma ...
Published by : Business TodayApril 20, 2023 3:09:00 AM
Mankind Pharma�s IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders. Hence, the company will not receive any net proceeds from the issue ...
Published by : Zee BusinessMay 12, 2020 3:30:00 AM
LTRN believes it can better stratify patient populations for improved trial results for previously failed Phase 3 trials drug candidates. LTRN believes it can better stratify patient populations ...
Published by : TheStreet.comJune 28, 2024 6:47:00 PM
Pune-based Emcure Pharmaceuticals is gearing up to launch ... band of ?960-1008 per share for its initial public offering (IPO), which will open for subscription from July 3 to July 5.
Published by : India InfolineJanuary 29, 2015 3:13:00 PM
If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close. If the biotech bull market hasn't reached 11 on the absurdity meter quite yet ...
Published by : TheStreet.comJune 30, 2024 3:29:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) Emcure ...
Published by : MintMay 3, 2023 7:02:00 PM
Mankind Pharma is likely to announce its share allotment status on May 3. The IPO received great demand from investors as the issue was subscribed 15.32 times. The shares will be listed on May 8 ...
Published by : Business Insider IndiaJune 29, 2024 3:30:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) The Pune ...
Published by : MintJune 20, 2024 11:23:00 PM
The IPO includes fresh equity sale worth ?800 crore and an OFS of 1.36 crore equity shares by promoters and existing shareholders. Emcure Pharma has received Sebi's nod for the IPO. The company ...
Published by : Hindustan TimesJune 28, 2024 1:25:00 AM
arlier this month, the company received Sebi's go-ahead to float the initial share sale. Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running ...
Published by : health.economictimes.indiatimesJuly 16, 2021 3:30:00 AM
Tatva Chintan Pharma Chem IPO opens on July 16 and closes on July 20. Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO).
Published by : Business Insider IndiaMarch 25, 2023 11:54:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalSudarshan Pharma Industries Limited is entering in the capital market with an IPO of 3,440,000 Equity Shares of Rs 10 aggregating up to Rs 24.77 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The issue opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME.
The issue of Sudarshan Pharma Industries Limited opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Sudarshan Pharma IPO is proposed to open on June 12, 2019. The IPO application ends on June 21, 2019.
Retail investors can apply in the retail or non-institutional investor category from June 12, 2019 to June 21, 2019. The Sudarshan Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Sudarshan Pharma IPO will open for subscription on June 12, 2019. The public issue will close on June 21, 2019.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|